Molecular aspects and the pathological basis of primary biliary cirrhosis

Patrick S Leung, Judith A Van de Water, Ross L. Coppel, Yasuni Nakanuma, Santiago Munoz, M. Eric Gershwin

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) has been considered to be a 'model autoimmune disease' for more than two decades. However, the underlying pathophysiology of PBC and the relationship with the associated serological abnormalities have been hitherto elusive. Beginning in 1987 with the cloning and subsequent identification of the mitochondrial autoantigens of PBC, progress has come rapidly and we can now sketch several potential pathogenic pathways through which disease occurs. More than 90% of patients with PBC produce autoantibodies to mitochondria, and the antoantigens involved have been identified as related components of the 2-oxo-acid dehydrogenase complexes (OADC), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), the branched chain 2-oxo-acid dehydrogenase complex and 2-oxo-glutarate dehydrogenase complex, Protein X and E1α. The cDNAs of each of the E2 subunits of OADC have been cloned and characterized. Moreover, the epitopes of the antimitochondrial antibodies (AMA) have been mapped at the highly conserved lipoyl domain E2 subunits. The use of recombinant peptides produced by these clones has greatly facilitated the detection of AMA. In addition, nucleotide sequence analysis of PDC-E2 specific human monoclonals and combinatorial Fabs strongly suggests that these autoantibodies are derived from clonal selection of a restricted set of somatically mutated immunoglobulin germline genes. Most interestingly, however, the use of monoclonal reagents to PDC-E2 has demonstrated that there is an increased expression of either PDC-E2, or a cross-reactive molecule, on the luminal surface of biliary epithelial cells in patients with PBC. These data provide a scenario to explain the tissue specific pathology associated with PBC and several interesting underlying pathophysiological mechanisms.

Original languageEnglish (US)
Pages (from-to)119-128
Number of pages10
JournalJournal of Autoimmunity
Volume9
Issue number2
DOIs
StatePublished - Apr 1996

Fingerprint

Biliary Liver Cirrhosis
Keto Acids
Oxidoreductases
Autoantibodies
Dihydrolipoyllysine-Residue Acetyltransferase
Glutarates
3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
Immunoglobulin Genes
Antibodies
Autoantigens
Autoimmune Diseases
Sequence Analysis
Organism Cloning
Epitopes
Mitochondria
Complementary DNA
Clone Cells
Epithelial Cells
Pathology
Peptides

Keywords

  • 2-oxo-acid dehydrogenase complex
  • Anti-mitochondrial autoantibodies
  • Biliary epithelial cells
  • Combinatorial autoantibodies
  • Cross-reactive molecule
  • HLA antigens
  • Ig genes
  • PDC-E2
  • T-cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Molecular aspects and the pathological basis of primary biliary cirrhosis. / Leung, Patrick S; Van de Water, Judith A; Coppel, Ross L.; Nakanuma, Yasuni; Munoz, Santiago; Gershwin, M. Eric.

In: Journal of Autoimmunity, Vol. 9, No. 2, 04.1996, p. 119-128.

Research output: Contribution to journalArticle

@article{367c32862c2646dab148895ff4dc4c67,
title = "Molecular aspects and the pathological basis of primary biliary cirrhosis",
abstract = "Primary biliary cirrhosis (PBC) has been considered to be a 'model autoimmune disease' for more than two decades. However, the underlying pathophysiology of PBC and the relationship with the associated serological abnormalities have been hitherto elusive. Beginning in 1987 with the cloning and subsequent identification of the mitochondrial autoantigens of PBC, progress has come rapidly and we can now sketch several potential pathogenic pathways through which disease occurs. More than 90{\%} of patients with PBC produce autoantibodies to mitochondria, and the antoantigens involved have been identified as related components of the 2-oxo-acid dehydrogenase complexes (OADC), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), the branched chain 2-oxo-acid dehydrogenase complex and 2-oxo-glutarate dehydrogenase complex, Protein X and E1α. The cDNAs of each of the E2 subunits of OADC have been cloned and characterized. Moreover, the epitopes of the antimitochondrial antibodies (AMA) have been mapped at the highly conserved lipoyl domain E2 subunits. The use of recombinant peptides produced by these clones has greatly facilitated the detection of AMA. In addition, nucleotide sequence analysis of PDC-E2 specific human monoclonals and combinatorial Fabs strongly suggests that these autoantibodies are derived from clonal selection of a restricted set of somatically mutated immunoglobulin germline genes. Most interestingly, however, the use of monoclonal reagents to PDC-E2 has demonstrated that there is an increased expression of either PDC-E2, or a cross-reactive molecule, on the luminal surface of biliary epithelial cells in patients with PBC. These data provide a scenario to explain the tissue specific pathology associated with PBC and several interesting underlying pathophysiological mechanisms.",
keywords = "2-oxo-acid dehydrogenase complex, Anti-mitochondrial autoantibodies, Biliary epithelial cells, Combinatorial autoantibodies, Cross-reactive molecule, HLA antigens, Ig genes, PDC-E2, T-cells",
author = "Leung, {Patrick S} and {Van de Water}, {Judith A} and Coppel, {Ross L.} and Yasuni Nakanuma and Santiago Munoz and Gershwin, {M. Eric}",
year = "1996",
month = "4",
doi = "10.1006/jaut.1996.0015",
language = "English (US)",
volume = "9",
pages = "119--128",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular aspects and the pathological basis of primary biliary cirrhosis

AU - Leung, Patrick S

AU - Van de Water, Judith A

AU - Coppel, Ross L.

AU - Nakanuma, Yasuni

AU - Munoz, Santiago

AU - Gershwin, M. Eric

PY - 1996/4

Y1 - 1996/4

N2 - Primary biliary cirrhosis (PBC) has been considered to be a 'model autoimmune disease' for more than two decades. However, the underlying pathophysiology of PBC and the relationship with the associated serological abnormalities have been hitherto elusive. Beginning in 1987 with the cloning and subsequent identification of the mitochondrial autoantigens of PBC, progress has come rapidly and we can now sketch several potential pathogenic pathways through which disease occurs. More than 90% of patients with PBC produce autoantibodies to mitochondria, and the antoantigens involved have been identified as related components of the 2-oxo-acid dehydrogenase complexes (OADC), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), the branched chain 2-oxo-acid dehydrogenase complex and 2-oxo-glutarate dehydrogenase complex, Protein X and E1α. The cDNAs of each of the E2 subunits of OADC have been cloned and characterized. Moreover, the epitopes of the antimitochondrial antibodies (AMA) have been mapped at the highly conserved lipoyl domain E2 subunits. The use of recombinant peptides produced by these clones has greatly facilitated the detection of AMA. In addition, nucleotide sequence analysis of PDC-E2 specific human monoclonals and combinatorial Fabs strongly suggests that these autoantibodies are derived from clonal selection of a restricted set of somatically mutated immunoglobulin germline genes. Most interestingly, however, the use of monoclonal reagents to PDC-E2 has demonstrated that there is an increased expression of either PDC-E2, or a cross-reactive molecule, on the luminal surface of biliary epithelial cells in patients with PBC. These data provide a scenario to explain the tissue specific pathology associated with PBC and several interesting underlying pathophysiological mechanisms.

AB - Primary biliary cirrhosis (PBC) has been considered to be a 'model autoimmune disease' for more than two decades. However, the underlying pathophysiology of PBC and the relationship with the associated serological abnormalities have been hitherto elusive. Beginning in 1987 with the cloning and subsequent identification of the mitochondrial autoantigens of PBC, progress has come rapidly and we can now sketch several potential pathogenic pathways through which disease occurs. More than 90% of patients with PBC produce autoantibodies to mitochondria, and the antoantigens involved have been identified as related components of the 2-oxo-acid dehydrogenase complexes (OADC), including the E2 subunits of the pyruvate dehydrogenase complex (PDC-E2), the branched chain 2-oxo-acid dehydrogenase complex and 2-oxo-glutarate dehydrogenase complex, Protein X and E1α. The cDNAs of each of the E2 subunits of OADC have been cloned and characterized. Moreover, the epitopes of the antimitochondrial antibodies (AMA) have been mapped at the highly conserved lipoyl domain E2 subunits. The use of recombinant peptides produced by these clones has greatly facilitated the detection of AMA. In addition, nucleotide sequence analysis of PDC-E2 specific human monoclonals and combinatorial Fabs strongly suggests that these autoantibodies are derived from clonal selection of a restricted set of somatically mutated immunoglobulin germline genes. Most interestingly, however, the use of monoclonal reagents to PDC-E2 has demonstrated that there is an increased expression of either PDC-E2, or a cross-reactive molecule, on the luminal surface of biliary epithelial cells in patients with PBC. These data provide a scenario to explain the tissue specific pathology associated with PBC and several interesting underlying pathophysiological mechanisms.

KW - 2-oxo-acid dehydrogenase complex

KW - Anti-mitochondrial autoantibodies

KW - Biliary epithelial cells

KW - Combinatorial autoantibodies

KW - Cross-reactive molecule

KW - HLA antigens

KW - Ig genes

KW - PDC-E2

KW - T-cells

UR - http://www.scopus.com/inward/record.url?scp=0029945543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029945543&partnerID=8YFLogxK

U2 - 10.1006/jaut.1996.0015

DO - 10.1006/jaut.1996.0015

M3 - Article

C2 - 8738955

AN - SCOPUS:0029945543

VL - 9

SP - 119

EP - 128

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 2

ER -